Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Fitoterapia ; 175: 105946, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38575087

RESUMO

Four compounds (1-4) featuring with an L-rhodinose and spiroketal, possess uncommon continuous hydroxy groups in the macrolide skeleton, and a dichloro-diketopiperazine (5) were isolated from a marine derived Micromonospora sp. FIMYZ51. The determination of the relative and absolute configurations of all isolates was achieved by extensive spectroscopic analyses, single-crystal X-ray diffraction analysis, and ECD calculations. According to structural characteristic and genomic sequences, a plausible biosynthetic pathway for compound 1-4 was proposed and a spirocyclase was inferred to be responsible for the formation of the rare spirocyclic moiety. Compounds 1-4 exhibited potent antifungal activities which is equal to itraconazole against Aspergillus niger. Compounds 1-5 exhibited different degree of inhibitory activities against opportunistic pathogenic bacteria of endocarditis (Micrococcus luteus) with MIC values ranging from 0.0625 µg/mL to 32 µg/mL. Compounds 2 and 3 showed moderate cytotoxicity against drug-resistant tumor cell lines (Namalwa and U266). The result not only provides active lead-compounds, but also reveal the potential of the spirocyclase gene resources from Micromonospora sp., which highlights the promising potential of the strain for biomedical applications.


Assuntos
Dicetopiperazinas , Macrolídeos , Micromonospora , Compostos de Espiro , Estrutura Molecular , Dicetopiperazinas/farmacologia , Dicetopiperazinas/isolamento & purificação , Dicetopiperazinas/química , Compostos de Espiro/farmacologia , Compostos de Espiro/isolamento & purificação , Compostos de Espiro/química , Linhagem Celular Tumoral , Humanos , Macrolídeos/farmacologia , Macrolídeos/isolamento & purificação , Macrolídeos/química , Antibacterianos/farmacologia , Antibacterianos/isolamento & purificação , Antibacterianos/química , Antifúngicos/farmacologia , Antifúngicos/isolamento & purificação , Antifúngicos/química , Testes de Sensibilidade Microbiana , China , Antineoplásicos/farmacologia , Antineoplásicos/isolamento & purificação , Antineoplásicos/química , Furanos
2.
Front Neurorobot ; 18: 1355857, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38362125

RESUMO

Introduction: Acupoint localization is integral to Traditional Chinese Medicine (TCM) acupuncture diagnosis and treatment. Employing intelligent detection models for recognizing facial acupoints can substantially enhance localization accuracy. Methods: This study introduces an advancement in the YOLOv8-pose keypoint detection algorithm, tailored for facial acupoints, and named YOLOv8-ACU. This model enhances acupoint feature extraction by integrating ECA attention, replaces the original neck module with a lighter Slim-neck module, and improves the loss function for GIoU. Results: The YOLOv8-ACU model achieves impressive accuracy, with an mAP@0.5 of 97.5% and an mAP@0.5-0.95 of 76.9% on our self-constructed datasets. It also marks a reduction in model parameters by 0.44M, model size by 0.82 MB, and GFLOPs by 9.3%. Discussion: With its enhanced recognition accuracy and efficiency, along with good generalization ability, YOLOv8-ACU provides significant reference value for facial acupoint localization and detection. This is particularly beneficial for Chinese medicine practitioners engaged in facial acupoint research and intelligent detection.

3.
Hosp Pediatr ; 13(12): 1056-1066, 2023 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-37916264

RESUMO

BACKGROUND AND OBJECTIVES: Families of children with medical complexity manage a multitude of care responsibilities that must be carefully coordinated alongside typical family roles and activities. Currently, little is known about this experience from the perspectives of caregivers; therefore, the purpose of this study was to explore the experience of caregiving for a child with medical complexity while identifying unmet medical and psychosocial needs. METHODS: Nineteen caregivers were recruited from the pediatric complex care clinic at an academic medical center in the United States. Each participant completed an in-depth, narrative interview that was audio-recorded and transcribed; transcripts were analyzed using an inductive coding approach. RESULTS: Participants described their caregiving experiences along 4 themes: (1) the many responsibilities of caregiving, (2) insufficient respite care and skilled support, (3) financial limitations and costs of care, and (4) challenges with mental health and wellbeing. Participants identified unmet needs in 6 dimensions: (1) transition stress, (2) communication across teams, (3) learning to be an advocate, (4) purposefully inclusive environments, (5) finding connections and community, and (6) the challenges of coronavirus disease 2019. CONCLUSIONS: Caregivers of children with medical complexity identify a host of experiences and unmet needs that challenge the physical, emotional, and psychosocial wellbeing of themselves and their families. With more attention to the holistic experience of caregiving for this population, providers and teams can better anticipate needs and provide services and programs that enhance caregiver and family wellbeing simultaneously.


Assuntos
Cuidadores , Saúde Mental , Humanos , Criança , Estados Unidos , Cuidadores/psicologia , Instituições de Assistência Ambulatorial , Comunicação
4.
Biochem Pharmacol ; 168: 214-223, 2019 10.
Artigo em Inglês | MEDLINE | ID: mdl-31306643

RESUMO

Targeting Trp-Kyn pathways has been identified as an attractive approach for the cancer immunotherapies. In this study, a novel phosphonamidate containing compound was designed, synthesized and evaluated for its inhibitory activity against key dioxygenases in Trp-Kyn pathway, including IDO1, IDO2 and TDO. This compound showed potent IDO1 inhibitory activity with an IC50 value of 94 nM in an enzymatic assay and 12.6 nM in HeLa cells. In addition, this compound showed promising IDO2 inhibition and TDO inhibition with IC50 values of 310 nM and 2.6 µM, respectively, in enzyme assay. Based on the promising enzyme inhibitory activity toward IDO/TDO, compound F04 was evaluated of its antitumor effects in two tumor models. Further evaluation of mechanism demonstrated compound F04 with the remarkable capacity of reducing kynurenine level in plasma/TME and restoring anti-tumor immune response. F04 could be further developed as a potential immunotherapeutic agent combined with immune checkpoint inhibitors or chemotherapeutic drugs for cancer treatment.


Assuntos
Antineoplásicos/síntese química , Sistemas de Liberação de Medicamentos/métodos , Indolamina-Pirrol 2,3,-Dioxigenase/antagonistas & inibidores , Fosfoaminoácidos/síntese química , Triptofano Oxigenase/antagonistas & inibidores , Administração Oral , Animais , Antineoplásicos/administração & dosagem , Células CACO-2 , Carcinoma Pulmonar de Lewis/tratamento farmacológico , Carcinoma Pulmonar de Lewis/metabolismo , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos/métodos , Células HeLa , Humanos , Indolamina-Pirrol 2,3,-Dioxigenase/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Fosfoaminoácidos/administração & dosagem , Triptofano Oxigenase/metabolismo , Ensaios Antitumorais Modelo de Xenoenxerto/métodos
5.
Zhongguo Zhong Yao Za Zhi ; 42(7): 1265-1270, 2017 Apr.
Artigo em Chinês | MEDLINE | ID: mdl-29052384

RESUMO

Serum pharmacochemistry of traditional Chinese medicine(TCM) is an effective method to rapidly screen the effective substances and reveal the compatibility law of compound by identification and analysis of constituents migrating to blood after oral administration. In the last two decades, it has been universally accepted and widely applied in the field. With the cross-fusion with other disciplines, such as serum pharmacology, pharmacokinetics, metabolomics, network pharmacology and systems biology, serum pharmacochemistry shows comprehensive superiority in explaining drug changes in vivo and in vitro, interactions between drugs, interactions between drug and body, which coincides with the complexity of TCM compatibility, multi-components, multi-targets and multi-mechanisms. Based on the references related with the serum pharmacochemistry from CNKI scholar and Pubmed in 2013-2016, the research results of serum pharmacochemistry were statistically analyzed, and the key technical problems during the study of serum pharmacochemistry, for example, preparation of test sample, selection of experimental animal, determination of drug delivery scheme, method and time of the adoption blood, preparation and pretreatment of blood sample, as well as analysis of constituents migrating to blood, and the solving ways were empirically introduced. In addition, the development and comprehensive application of serum pharmacochemistry in TCM were summarized in this paper, hoping to lay a foundation for the further application of this method in TCM research.


Assuntos
Avaliação Pré-Clínica de Medicamentos , Medicina Tradicional Chinesa , Soro/química , Animais , Medicamentos de Ervas Chinesas , Metabolômica , Biologia de Sistemas
6.
J Pharmacol Sci ; 123(2): 195-8, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24096829

RESUMO

We investigated the anticonvulsant effect of acute Fuzi total alkaloid (FTA) in seizure induced by the GABAA-receptor antagonist pentylenetetrazole (PTZ). FTA significantly increased the seizure latency and decreased the mortality in PTZ-treated mice. Administration of PTZ increased c-Fos expression in the hippocampus, medial prefrontal cortex, and piriform cortex; and this PTZ-induced effect was inhibited by FTA in a dose-dependent manner. Furthermore, the effects of FTA on PTZ-induced seizure and c-Fos expression were reversed by the GABAA/benzodiazepine receptor-selective antagonist flumazenil. These findings suggest that the anticonvulsant effects of FTA may be related to modulation of GABAA-benzodiazepine receptor complex.


Assuntos
Anticonvulsivantes/farmacologia , Antagonistas de Receptores de GABA-A , Pentilenotetrazol , Fitoterapia , Extratos Vegetais/farmacologia , Receptores de GABA-A/metabolismo , Convulsões/induzido quimicamente , Convulsões/tratamento farmacológico , Animais , Córtex Cerebral/metabolismo , Modelos Animais de Doenças , Diterpenos , Relação Dose-Resposta a Droga , Medicamentos de Ervas Chinesas , Flumazenil/farmacologia , Hipocampo/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos ICR , Pentilenotetrazol/antagonistas & inibidores , Proteínas Proto-Oncogênicas c-fos/metabolismo , Convulsões/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA